📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

P592 Efficacy of vedolizumab for induction and maintenance of clinical remission in ulcerative colitis: The UCLH experience (2018)

First Author: Vinayaga-Pavan M

Attributed to: Pathogenesis of Ulcerative colitis: The role of BRINP3 in colonic epithelial barrier function and mucosal inflammation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ecco-jcc/jjx180.719

Publication URI: http://dx.doi.org/10.1093/ecco-jcc/jjx180.719

Type: Journal Article/Review

Parent Publication: Journal of Crohn's and Colitis

Issue: supplement_1